Impact of regional striatal dopaminergic function on kinematic parameters of Parkinson’s disease

被引:0
|
作者
Myung Jun Lee
Sha-Lom Kim
Chul Hyoung Lyoo
J. O. Rinne
Myung-Sik Lee
机构
[1] Pusan National University Hospital,Department of Neurology
[2] Pusan National University School of Medicine and Medical Research Institute,Department of Neurology
[3] Gangnam Severance Hospital,PET Center
[4] Yonsei University of College of Medicine,undefined
[5] University of Turku,undefined
来源
关键词
FP-CIT PET; Finger tapping; Kinematic analysis; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Among the cardinal parkinsonian motor deficits, the severity of bradykinesia correlates with striatal dopamine loss. However, the impact of regional striatal dopamine loss on specific components of bradykinesia remains unknown. Using gyroscopes, we measured the amplitude, speed, and frequency of finger tapping in 24 untreated patients with Parkinson’s disease (PD) and 28 healthy controls. Using positron emission tomography (PET) studies and [18F]-N-3-fluoropropyl-2-beta-carboxymethoxy-3-beta-(4-iodophenyl) nortropane (FP-CIT) in PD patients, we investigated the relationship between the mean values, variability and decrements of various kinematic parameters of finger tapping on one side (e.g. the mean, variability and decrement) and contralateral striatal FP-CIT binding. Compared with controls, PD patients had reduced amplitudes and speeds of tapping and showed greater decrement in those parameters. PD patients also exhibited greater irregularity in amplitude, speed, and frequency. Putaminal FP-CIT uptake levels correlated with the mean speed and amplitude, and caudate uptake levels correlated with mean amplitude. The variability of amplitude and speed correlated only with the caudate uptake levels. Neither caudate nor putaminal uptake correlated with frequency-related parameters or decrement in amplitude or speed. Reduced amplitude and speed of repetitive movement may be related to striatal dopaminergic deficit. Dopaminergic action in the caudate nucleus is required to maintain consistency of amplitude and speed. Although decrement of amplitude and speed is known to be specific for PD, we found that it did not mirror the degree of striatal dopamine depletion.
引用
收藏
页码:669 / 677
页数:8
相关论文
共 50 条
  • [11] Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease
    Jaakkola, E.
    Joutsa, J.
    Maekinen, E.
    Johansson, J.
    Kaasinen, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (11) : 1341 - 1347
  • [12] Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease
    Kaur, Karamjeet
    Gill, Jaskamal Singh
    Bansal, Puneet Kumar
    Deshmukh, Rahul
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 308 - 314
  • [13] Effect of polygenic load on striatal dopaminergic deterioration in Parkinson's disease
    Pak, K. J.
    Lee, M. J.
    MOVEMENT DISORDERS, 2019, 34 : S188 - S189
  • [14] Regional imbalance of striatal dopaminergic function in Parkinson's disease visualized with 11C-CFT and 11C-raclopride PET
    Suzuki, Masahiko
    Ishii, Kenji
    Inoue, Kiyoharu
    Mishina, Masahiro
    PARKINSONISM & RELATED DISORDERS, 2006, 12 : S90 - S90
  • [15] Dopaminergic medication effect on speech in Parkinson's disease: A kinematic study
    Tong, T. E.
    Ng, M. L.
    Yan, N.
    MOVEMENT DISORDERS, 2016, 31 : S611 - S611
  • [16] Smoking history and regional dopaminergic innervation in Parkinson's disease
    Black, K. J.
    Warren, S. L.
    Hartlein, J. M.
    Chang, J. N.
    Przybeck, T.
    Heath, A. C.
    Madden, P.
    Cloninger, C. R.
    Perlmutter, J. S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 290 - 291
  • [17] Dopaminergic agonist and cognitive function in Parkinson's disease
    Relja, M
    Klepac, N
    Subotic, Z
    PERIODICUM BIOLOGORUM, 2002, 104 (01) : 43 - 45
  • [18] Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease
    Pak, K. J.
    Shin, H. K.
    Kim, E. J.
    Lee, J. H.
    Lyoo, C. H.
    Son, J. S.
    Lee, M. J.
    Son, H. J.
    MOVEMENT DISORDERS, 2018, 33 : S744 - S745
  • [19] Ventral striatal dopaminergic defect is a risk factor for hallucinations in Parkinson's disease
    Jaakkola, E.
    Joutsa, J.
    Makinen, E.
    Johansson, J.
    Kaasinen, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 93 - 93
  • [20] Role of striatal interdependence in the compensation of dopaminergic depletion in early Parkinson's disease
    Juri, C.
    Arbizu, J.
    Blesa, J.
    Rodriguez-Oroz, M.
    Iglesias, E.
    Prieto, E.
    Collantes, M.
    Penuelas, I.
    Obeso, J. A.
    MOVEMENT DISORDERS, 2010, 25 (07) : S384 - S385